Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.

Lu, Ying-Ying

Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line. [electronic resource] - World journal of gastroenterology Sep 2008 - 5403-11 p. digital

Publication Type: Journal Article

2219-2840

10.3748/wjg.14.5403 doi


Adenocarcinoma--drug therapy
Animals
Antineoplastic Agents--therapeutic use
Apoptosis--drug effects
Cell Cycle--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Neovascularization, Pathologic--drug therapy
Pancreatic Neoplasms--drug therapy
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Transplantation, Heterologous
Vascular Endothelial Growth Factor A--genetics